BRCA Genes in Breast Cancer Chemoprevention
BRCA 基因在乳腺癌化学预防中的作用
基本信息
- 批准号:7416594
- 负责人:
- 金额:$ 28.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntioxidantsBRCA1 MutationBRCA1 geneBRCA2 geneBiological AssayBreastBreast Cancer PreventionCancer-Predisposing GeneCarcinogen MetabolismCarcinogensCategoriesCell LineCellsCervicalChemopreventionChemopreventive AgentClinicalDNA DamageDNA Microarray ChipDNA Microarray formatDataDietary SupplementationEndometrial CarcinomaEpithelial CellsEstrogensExonsExperimental Animal ModelExperimental ModelsFigs - dietaryGene ExpressionGene Expression ProfilingGenesGenetic TranscriptionGlutathioneGoalsGrowthHereditary Breast CarcinomaHormonesHumanIn VitroIndole-3-CarbinolMalignant neoplasm of cervix uteriMalignant neoplasm of prostateMammary TumorigenesisMammary glandMediatingMessenger RNAMetabolismModelingMolecularMolecular TargetMusMutationOutcome StudyPathway interactionsPatternPhytochemicalPreventionProstateProteinsPublishingRiskRoleSmall Interfering RNATamoxifenTestingToxic effectTranscriptional ActivationTumor Suppressor ProteinsUp-RegulationWomancancer typecell growthcruciferous vegetablefallsin vivomalignant breast neoplasmmouse modelpreventrepairedresponsesulfotransferasetranscription factortumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Background. Clinical-epidemiological and animal model studies suggest that indole-3-carbinol [I3C, a phytochemical from cruciferous vegetables] has chemopreventive activity for hormone-dependent tumor types, including breast, cervical, and endometrial cancers. Its anti-tumor activity is probably due to both hormone-dependent and hormone independent actions. Mutations of the breast cancer susceptibility genes BRCA1 and BRCA2 each confer a significantly increased risk of several hormonally-responsive cancer types (e.g., breast and prostate cancers). Preliminary studies. Our published and preliminary studies suggest that some of the hormone-dependent and hormone-independent actions of DC in human breast, cervical cancer, and prostate cell lines are mediated through the up-regulation of BRCA1 and BRCA2 expression. Gene expression profiling using DNA microarrays suggest an overlap between the gene expression patterns induced by DM (the major active metabolite of ISC) vs BRCA1. Hypothesis. We postulate that chemoprevention by I3C is due, in part, to BRCA1 (and probably BRCA2) mediated activities: e.g., inhibition of E2-stimulated cell growth and up-regulation of growth arrest and DNA damage-responsive genes (GADDs) and GSTs. I3C may also induce these and other tumor suppressor pathways independently of BRCA1; and BRCA1/2 may function synergistically with these other I3C pathways to suppress tumorigenesis. Objectives. To test these hypotheses, we will carry out three specific aims. In SA1, we will investigate the mechanism by which I3C induces BRCA1 and BRCA2; and we will assess the contribution of the endogenous BRCA genes to the estrogen-dependent and estrogen-independent molecular and cellular actions of I3C in human mammary epithelial cells, using small interfering RNAs to each BRCA gene that we have already developed. In SA2, we will assess the roles of the BRCA genes in the spectrum of DBVI-induced transcriptional alterations in mammary epithelial cells. And in SA3, we will validate some of these in vitro observations using two in vivo experimental models for prevention of mammary cancer by dietary supplementation with I3C. One model will feature a mammary-targeted mutation of Brcal. Significance. These studies will establish that the BRCA genes are molecular targets for indole-3-carbinol that contribute to its ability to prevent breast cancer. A successful outcome of these studies would suggest the use of I3C in chemoprevention of sporadic and hereditary breast cancers. The latter may be particularly useful, since recent studies suggest that Tamoxifen may not protect women with BRCA1 mutations from developing breast cancer.
描述(由申请人提供):背景。临床流行病学和动物模型研究表明,吲哚-3-甲醇[I3 C,一种来自十字花科蔬菜的植物化学物质]对乳腺癌、子宫颈癌和子宫内膜癌等乳腺癌依赖性肿瘤类型具有化学预防活性。其抗肿瘤活性可能是由于激素依赖性和激素非依赖性作用。乳腺癌易感基因BRCA 1和BRCA 2的突变各自赋予几种对乳腺癌有反应的癌症类型(例如,乳腺癌和前列腺癌)。初步研究。我们已发表的和初步的研究表明,在人乳腺癌,宫颈癌和前列腺癌细胞系中,DC的一些依赖于乳腺癌和非依赖于乳腺癌的作用是通过上调BRCA 1和BRCA 2的表达来介导的。使用DNA微阵列的基因表达谱表明DM(ISC的主要活性代谢产物)与BRCA 1诱导的基因表达模式之间存在重叠。假说.我们假设I3 C的化学预防部分是由于BRCA 1(可能还有BRCA 2)介导的活性:例如,抑制E2刺激的细胞生长和上调生长停滞和DNA损伤应答基因(GADD)和GST。I3 C也可以独立于BRCA 1诱导这些和其他肿瘤抑制途径; BRCA 1/2可以与这些其他I3 C途径协同作用以抑制肿瘤发生。目标.为了验证这些假设,我们将实现三个具体目标。在SA 1中,我们将研究I3 C诱导BRCA 1和BRCA 2的机制;我们将评估内源性BRCA基因对I3 C在人乳腺上皮细胞中的雌激素依赖性和雌激素非依赖性分子和细胞作用的贡献,使用我们已经开发的每个BRCA基因的小干扰RNA。在SA 2中,我们将评估BRCA基因在DBVI诱导的乳腺上皮细胞转录改变谱中的作用。在SA 3中,我们将使用两种通过膳食补充I3 C预防乳腺癌的体内实验模型来验证其中一些体外观察结果。一个模型将以乳腺靶向突变的Brcal为特征。意义这些研究将确定BRCA基因是吲哚-3-甲醇的分子靶点,有助于其预防乳腺癌的能力。这些研究的成功结果表明I3 C在散发性和遗传性乳腺癌的化学预防中的应用。后者可能特别有用,因为最近的研究表明,他莫昔芬可能不能保护BRCA 1突变的女性患乳腺癌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eliot M. Rosen其他文献
Regulation of progesterone receptor signaling by BRCA1 in mammary cancer
BRCA1 对乳腺癌中孕酮受体信号传导的调节
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Pragati Katiyar;Yongxian Ma;Saijun Fan;R. Pestell;Priscilla A. Furth;Eliot M. Rosen - 通讯作者:
Eliot M. Rosen
Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epi
肝细胞生长因子/分散因子对上皮细胞的影响。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:15.9
- 作者:
Asma Nusrat;C. Parkos;A. E. Bacarra;P. Godowski;C. Delp;Eliot M. Rosen;J. L. Madara - 通讯作者:
J. L. Madara
P53-independent downregulation of p73 in human cancer cells treated with Adriamycin
- DOI:
10.1007/s002800000196 - 发表时间:
2001-02-01 - 期刊:
- 影响因子:2.300
- 作者:
Renqi Yuan;Qinghui Meng;Hao Hu;Itzhak D. Goldberg;Eliot M. Rosen;Saijun Fan - 通讯作者:
Saijun Fan
Microbeam radiation therapy: tissue dose penetration and BANG-gel dosimetry of thick-beams' array interlacing.
微束放射治疗:组织剂量穿透和厚束阵列交错的 BANG-gel 剂量测定。
- DOI:
10.1016/j.ejrad.2008.04.055 - 发表时间:
2008 - 期刊:
- 影响因子:3.3
- 作者:
F. Dilmanian;P. Romanelli;Z. Zhong;Ruiliang Wang;Mark E Wagshul;J. Kalef;Marek J. Maryanski;Eliot M. Rosen;David J. Anschel - 通讯作者:
David J. Anschel
Response of rat intracranial 9 L gliosarcoma to microbeam radiation therapy 1
大鼠颅内9L胶质肉瘤对微束放射治疗的反应1
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
F. Dilmanian;T. Button;Géraldine Le Duc;Nan Zhong;Louis A. Peña;Jennifer A. L. Smith;Steve R. Martinez;T. Bacarian;J. Tammam;Baorui Ren;Peter M. Farmer;John Kalef;P. Micca;M. Nawrocky;James A. Niederer;F. Recksiek;Alexander Fuchs;Eliot M. Rosen - 通讯作者:
Eliot M. Rosen
Eliot M. Rosen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eliot M. Rosen', 18)}}的其他基金
Enhancing cancer treatment by normal tissue protection
通过保护正常组织增强癌症治疗
- 批准号:
8671485 - 财政年份:2014
- 资助金额:
$ 28.61万 - 项目类别:
Development of BRCA1-mimetic drugs for breast cancer
乳腺癌 BRCA1 模拟药物的开发
- 批准号:
8403554 - 财政年份:2010
- 资助金额:
$ 28.61万 - 项目类别:
Development of BRCA1-mimetic drugs for breast cancer
乳腺癌 BRCA1 模拟药物的开发
- 批准号:
8610151 - 财政年份:2010
- 资助金额:
$ 28.61万 - 项目类别:
Development of BRCA1-mimetic drugs for breast cancer
乳腺癌 BRCA1 模拟药物的开发
- 批准号:
8022946 - 财政年份:2010
- 资助金额:
$ 28.61万 - 项目类别:
Development of BRCA1-mimetic drugs for breast cancer
乳腺癌 BRCA1 模拟药物的开发
- 批准号:
8207275 - 财政年份:2010
- 资助金额:
$ 28.61万 - 项目类别:
BRCA Genes in Breast Cancer Chemoprevention
BRCA 基因在乳腺癌化学预防中的作用
- 批准号:
6925842 - 财政年份:2005
- 资助金额:
$ 28.61万 - 项目类别:
BRCA Genes in Breast Cancer Chemoprevention
BRCA 基因在乳腺癌化学预防中的作用
- 批准号:
7024493 - 财政年份:2005
- 资助金额:
$ 28.61万 - 项目类别:
BRCA Genes in Breast Cancer Chemoprevention
BRCA 基因在乳腺癌化学预防中的作用
- 批准号:
7614406 - 财政年份:2005
- 资助金额:
$ 28.61万 - 项目类别:
BRCA Genes in Breast Cancer Chemoprevention
BRCA 基因在乳腺癌化学预防中的作用
- 批准号:
7227848 - 财政年份:2005
- 资助金额:
$ 28.61万 - 项目类别:
ROLE OF BRCA1 AS A HUMAN PROSTATE SUPPRESSOR GENE
BRCA1 作为人类前列腺抑制基因的作用
- 批准号:
6173750 - 财政年份:1999
- 资助金额:
$ 28.61万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 28.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 28.61万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 28.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 28.61万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 28.61万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 28.61万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 28.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 28.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 28.61万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 28.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




